Results 21 to 30 of about 23,301 (196)
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma
Heliyon, 2019 IFI16, member of the IFN-inducible PYHIN-200 gene family, modulates proliferation, survival and differentiation of different cell lineages. In particular, IFI16 expression, which is regulated during the differentiation of B cells, was recently studied in
Pier Paolo Piccaluga +13 more
doaj +1 more source
Multiple lymphomatous polyposis: A presentation for mantle cell lymphoma
Clinical Case Reports, 2020 Multiple lymphomatous polyposis is an uncommon presentation of mantle cell lymphoma, and when exhibited should prompt clinicians to incorporate mantle cell lymphoma into their differential workup.
Cory Gallivan, Ali Akbar
doaj +1 more source
Acalabrutinib for mantle cell lymphoma [PDF]
Blood, 2019 AbstractMantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but experience multiple relapses. Acalabrutinib is a novel second-generation oral Bruton tyrosine kinase inhibitor approved by the US Food and Drug Administration for relapsed MCL based on a
David Inwards, Thomas E. Witzig
openaire +2 more sources
A Rare Case of Severe Lactic Acidosis in a Patient With Mantle Cell Lymphoma
Journal of Investigative Medicine High Impact Case Reports, 2021 Lactic acidosis is an extremely rare paraneoplastic manifestation of hematological malignancies, and often carries an extremely poor prognosis. Mantle cell lymphoma is an aggressive and rare form of non-Hodgkin lymphoma.
Kok Hoe Chan MD +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2009 Background Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin's lymphoma that originates from small to medium sized lymphocytes located in the mantle zone of the lymph node. Extra nodal involvement is present in the majority of cases,
Abo Stephen M +6 more
doaj +1 more source
RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma. [PDF]
PLoS ONE, 2012 Mantle cell lymphoma is characterized by a genetic translocation results in aberrant overexpression of the CCND1 gene, which encodes cyclin D1. This protein functions as a regulator of the cell cycle progression, hence is considered to play an important ...
Shiri Weinstein +8 more
doaj +1 more source
Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion
Case Reports in Hematology, 2020 Mantle cell lymphoma is a non-Hodgkin lymphoproliferative neoplasm with several clinical and morphologic variants linked, primarily, through genetic derangement of the cyclin D1 locus.
Robert K. McCall +2 more
doaj +1 more source
Mantle Cell Lymphoma Presenting with Acute Bilateral Ophthalmoplegia
Türk Oftalmoloji Dergisi, 2017 A 72-year-old woman presented with acute onset of double vision, bilateral complete blepharoptosis, and nearly complete ophthalmoplegia. Orbital and brain magnetic resonance imaging were normal.
Yaran Koban +6 more
doaj +1 more source
Mantle cell lymphoma of the colon [PDF]
Endoscopy, 2014 An 81-year-old man with a history of stage IV mantle cell lymphoma (MCL) diagnosed from a submental lymph node biopsy in 2006 was evaluated for new-onset melena and blood clots with bowel movements. He had been treated for his MCL with 6 cycles of CHOP-R (cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab) in 2006, followed by 13 ...
Mohammad, Esmadi +3 more
openaire +2 more sources
Primary gastric mantle cell lymphoma
Hematology Reports, 2012 Mantle cell lymphoma represents 2,5-7% all of non Hodgkin’s lymphomas. Stomach is the most common site of extranodal lymphoma. However, that is not the case with mantle cell lymphoma, which is extremely rare.
Duska Petranovic +7 more
doaj +1 more source